Early Development & IND Enablement
Route scouting, process research, analytical method development, and early regulatory support to move your program forward with clarity.
Learn moreMeet us at CPHI Milan 2026, Booth No. 10H33, Oct 6-8, Fiera Milano, Italy Schedule a Meeting
From route scouting and process development to commercial API manufacturing, we help pharmaceutical and biotech companies accelerate development with scalable, regulatory-compliant CDMO solutions.
Explore Our CDMO Services
Phase-appropriate development and manufacturing support designed to reduce complexity, improve readiness, and accelerate progress from early development through commercial supply.
Route scouting, process research, analytical method development, and early regulatory support to move your program forward with clarity.
Learn more
Process optimization, impurity control, analytical alignment, and seamless technology transfer to support scale-up with confidence.
Learn more
cGMP manufacturing, quality systems, and supply continuity from clinical phase needs through commercial launch.
Learn moreNeuland’s small molecule CDMO services combine complex chemistry, scalable development, and commercial manufacturing to deliver reliable, regulator-ready API supply with reduced risk and long-term supply assurance.
Explore Small Molecule CDMO Services
Chemistry & Reactions
Process Development
Scale-Up & Tech Transfer
Quality & Compliance
Analytical R&D
Regulatory CMC
Commercial ManufacturingLeveraging SPPS, LPPS, and hybrid approaches, we deliver sequence-specific peptides with the quality, scalability, and consistency required for clinical and commercial success.
Explore Peptide CDMO Services
SPPS & LPPSProcess Development
Hybrid SynthesisQuality & ComplianceAnalytical R&DRegulatory CMCCommercial ManufacturingPartner with us for dependable API manufacturing backed by strong process expertise, global regulatory track record, and a focus on uninterrupted commercial supply.
Explore Our API PortfolioComplex Synthetic ChemistryProcess OptimizationScale-Up & Tech TransferQuality & ComplianceAnalytical R&DGlobal DMF FilingsCommercial Manufacturing
Built on process expertise, execution discipline, and regulatory rigor.
Transparent, responsive engagement across every stage of your program.
Proven ability to solve challenging process and impurity problems.
cGMP systems aligned to global regulatory expectations.
From development through commercial supply with continuity.
Trusted by 500+ pharma and biotech companies globally
Tell us about your molecule or development challenge. Our experts will connect with you to explore practical, scalable solutions from early development to commercial supply.
Trusted by 500+ pharma and biotech companies globally | We look forward to partnering with you.
Quick answers to help you better understand our CDMO capabilities and approach.
Still Have Questions? Contact UsNeuland provides integrated end-to-end CDMO services covering early-stage route scouting, process development, analytical R&D, clinical trial material manufacturing, and commercial-scale cGMP API manufacturing for complex small molecules and peptides.
With over four decades of synthetic chemistry expertise, Neuland supports challenging chemical entities through robust route design, process optimization, impurity profiling, and scalable synthesis across state-of-the-art cGMP facilities.
Neuland offers specialized peptide synthesis leveraging solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), and hybrid synthesis methodologies, enabling high-purity, sequence-specific peptides with seamless transition to commercial volume.
Neuland operates three USFDA-inspected cGMP manufacturing facilities with a successful track record of 18 inspections and zero critical observations, fully aligned with global regulatory authorities including EMA, PMDA, and EDQM.
Our experienced technical transfer teams utilize disciplined stage-gate methodology, rigorous process validation, and process safety evaluations to de-risk commercial scale-up and ensure long-term supply continuity.
